Abstract

Purpose: Variations in the radiosensitivty of different tumours pertain to the potential for therapeutic gain for treatment with high energy neutrons. In this work the radiosensitivities of T-lymphocytes of different individuals to the clinical neutron beam at iThemba LABS were measured. The objective of this investigation was to establish if a relationship between neutron RBE and resistance to conventional gamma radiation could be determined. Materials and Methods: Peripheral blood samples were collected from five healthy donors. Whole blood was exposed to different doses of 60Co gamma rays (1-5 Gy) and p(66)/Be neutrons (0.5-2.5 Gy). One sample per donor was not exposed to radiation and served as a control. From each sample, lymphocytes were separated and cultured to induce micronuclei in cytokinesis-blocked cells. The micronuclei yield and nucleation index were assessed using fluorescent microscopy. Radiosensitiviies and RBE values were calculated from the fitted dose response micronuclei frequency data. Results: Dose limiting RBE values for the clinical neutron beam were found to range from 1.8 to 11.2 with a mean value of 6.5 ± 3.4. A clear reduction in neutron RBE is noted for donors with lymphocytes more sensitive to gamma rays (p = 0.05, R2 = 0.9). Conclusion: The correlation between neutron RBE and cellular radioresistance to photons suggests a potential for therapeutic gain for some patients treated with the high energy neutron beam at iThemba LABS.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.